select a format

Single User License
USD 125 INR 8036
Site License
USD 250 INR 16073
Corporate User License
USD 375 INR 24109

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Torrent Pharmaceuticals Ltd (TORNTPHARM)-Financial and Strategic SWOT Analysis Review

Torrent Pharmaceuticals Ltd (TORNTPHARM)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH81839FSA
  • |
  • Pages: 41
  • |
  • August 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Torrent Pharmaceuticals Ltd (TORNTPHARM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrology, cancer, gynecology and pediatric segments. Torrent has a fully equipped research center that is approved by the US FDA and various other regulatory authorities and manufacturing facilities at Indrad, Baddi, Sikkim, Dahej and Pithampur. The company has presence in more than forty countries worldwide and has wholly owned subsidiaries in USA, the UK, Germany, Russia, Brazil, Mexico, Philippines and other major markets. Torrent is headquartered in Ahmedabad, Gujarat, India.

Torrent Pharmaceuticals Ltd Key Recent Developments

Jul 22,2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company

May 26,2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017

Oct 26,2016: Torrent Pharma announces Q2 FY 2016-17 Results

Jul 27,2016: Torrent Pharma announces Q1 FY 2016-17 Results

May 23,2016: Torrent Pharma announces Q4 FY 2015-16 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Torrent Pharmaceuticals Ltd-Key Facts 5

Torrent Pharmaceuticals Ltd-Key Employees 6

Torrent Pharmaceuticals Ltd-Key Employee Biographies 7

Torrent Pharmaceuticals Ltd-Major Products and Services 8

Torrent Pharmaceuticals Ltd-History 9

Torrent Pharmaceuticals Ltd-Locations And Subsidiaries 10

Head Office 10

Other Locations & Subsidiaries 10

Section 2-Company Analysis 12

Torrent Pharmaceuticals Ltd-Business Description 12

Torrent Pharmaceuticals Ltd-Corporate Strategy 13

Torrent Pharmaceuticals Ltd-SWOT Analysis 14

SWOT Analysis-Overview 14

Torrent Pharmaceuticals Ltd-Strengths 14

Torrent Pharmaceuticals Ltd-Weaknesses 15

Torrent Pharmaceuticals Ltd-Opportunities 16

Torrent Pharmaceuticals Ltd-Threats 17

Torrent Pharmaceuticals Ltd-Key Competitors 18

Section 3-Company Financial Ratios 19

Financial Ratios-Capital Market Ratios 19

Financial Ratios-Annual Ratios 20

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Torrent Pharmaceuticals Ltd, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Jul 22, 2017: Torrent Pharmaceuticals : Intimation of Resignation of Director of the Company 29

May 26, 2017: Torrent Pharmaceuticals Reports Revenue Of INR19.8 Billion In Fiscal 2017 30

Oct 26, 2016: Torrent Pharma announces Q2 FY 2016-17 Results 31

Jul 27, 2016: Torrent Pharma announces Q1 FY 2016-17 Results 33

May 23, 2016: Torrent Pharma announces Q4 FY 2015-16 Results 34

Mar 18, 2016: Torrent Pharma's Dahej Plant receives EIR from US FDA 35

Feb 04, 2016: Torrent Pharma announces Q3 FY 2015-16 results. Declares interim Dividend of 400% (Rs 20 per share) 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Torrent Pharmaceuticals Ltd, Performance Chart (2013-2017) 23

Torrent Pharmaceuticals Ltd, Ratio Charts 25

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

List of Tables

Torrent Pharmaceuticals Ltd, Key Facts 5

Torrent Pharmaceuticals Ltd, Key Employees 6

Torrent Pharmaceuticals Ltd, Key Employee Biographies 7

Torrent Pharmaceuticals Ltd, Major Products and Services 8

Torrent Pharmaceuticals Ltd, History 9

Torrent Pharmaceuticals Ltd, Other Locations 10

Torrent Pharmaceuticals Ltd, Subsidiaries 10

Torrent Pharmaceuticals Ltd, Key Competitors 18

Torrent Pharmaceuticals Ltd, Ratios based on current share price 19

Torrent Pharmaceuticals Ltd, Annual Ratios 20

Torrent Pharmaceuticals Ltd, Annual Ratios (Cont...1) 21

Torrent Pharmaceuticals Ltd, Annual Ratios (Cont...2) 22

Torrent Pharmaceuticals Ltd, Interim Ratios 24

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

Torrent Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

Torrent Pharmaceuticals Ltd, Recent Deals Summary 28

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Torrent Pharmaceuticals Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com